Yang Ming-Lang, Tao Tao, Xu Jian, Liu Zhi, Xu Dan
Department of Rehabilitation Medicine, Affiliated People's Hospital, Guizhou Medical University, Guiyang, Guizhou 550002, China.
Department of Rehabilitation Medicine, Guizhou Provincial People's Hospital, Guiyang, Guizhou 550002, China.
Chin Med J (Engl). 2017 Jul 20;130(14):1700-1706. doi: 10.4103/0366-6999.209909.
Mounting evidence has demonstrated that hypoxia-inducible factor-1α (HIF-1α) could attenuate brain injuries after cerebral ischemia and reperfusion (CIR). However, few reports have addressed the therapeutic efficacies of a recombinant adenovirus vector containing HIF-1α (AdHIF-1α) gene after ischemia and reperfusion. The aim of this study was to examine the antiapoptotic and neuroprotective effects of AdHIF-1α gene for cerebral injuries after ischemia and reperfusion in rats.
From February to December 2016, male Sprague-Dawley rats were randomly divided into normal, sham, CIR, AdHIF-1α, and recombinant adenovirus (Ad) groups. Middle cerebral artery occlusion model was established by Longa's method and reperfusion resumed at 2 h postocclusion. AdHIF-1α solution, Ad solution, and phosphate-buffered saline were injected into the right lateral ventricle of rats in AdHIF-1α, Ad, and CIR groups. Brain tissue sections were observed under fluorescent microscope to confirm the definite expression of recombinant adenovirus in Ad and AdHIF-1α groups. The expressions of HIF-1α protein were analyzed by immunohistochemical staining at 6 h, 24 h, and 72 h postreperfusion. Brain water content and neurological deficit scores were evaluated at 6 h, 24 h, and 72 h postreperfusion. Pathological brain injuries were examined after hematoxylin and eosin stain and nerve cell apoptosis was measured after terminal-deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) stain at 72 h postreperfusion. Comparisons were conducted with one-way analysis of variance by post hoc Scheffe's test among different experimental groups.
Green fluorescent protein was successfully expressed in brain tissue of Ad and AdHIF-1α groups from 24 h to 21 days postinjection. As detected by immunohistochemical staining, the expressions of HIF-1α protein were obviously enhanced in AdHIF-1α group than those in CIR and Ad groups at 24 h and 72 h postreperfusion, respectively. There were significant reductions of brain water content (78.83% ± 0.34% vs. 83.21% ± 0.50% and 83.35% ± 0.32%; 84.13% ± 0.24% vs. 89.76% ± 0.34% and 89.70% ± 0.18%; respectively; all P < 0.05) and neurological deficit scores (2.90 ± 0.74 vs. 3.50 ± 0.52 and 3.60 ± 0.53 at 24 h; 2.40 ± 0.84 vs. 3.60 ± 0.52 and 3.50 ± 0.53 at 72 h; respectively; all P < 0.05) in AdHIF-1α group versus CIR and Ad groups at 24 h and 72 h postreperfusion, respectively. The pathologic changes of AdHIF-1α group were milder than those in CIR and Ad groups at 72 h postreperfusion. The percentage of TUNEL-positive cells in cerebral subcortex decreased significantly in AdHIF-1α group versus CIR and Ad groups at 72 h postreperfusion (P < 0.05).
AdHIF-1α has an obvious neuroprotective effect on ischemia and reperfusion in rat brains possibly through inhibiting the apoptosis of nerve cells.
越来越多的证据表明,缺氧诱导因子-1α(HIF-1α)可减轻脑缺血再灌注(CIR)后的脑损伤。然而,关于含HIF-1α(AdHIF-1α)基因的重组腺病毒载体在缺血再灌注后的治疗效果,鲜有报道。本研究旨在探讨AdHIF-1α基因对大鼠缺血再灌注后脑损伤的抗凋亡和神经保护作用。
2016年2月至12月,将雄性Sprague-Dawley大鼠随机分为正常组、假手术组、CIR组、AdHIF-1α组和重组腺病毒(Ad)组。采用Longa法建立大脑中动脉闭塞模型,闭塞2小时后恢复再灌注。将AdHIF-1α溶液、Ad溶液和磷酸盐缓冲盐水分别注入AdHIF-1α组、Ad组和CIR组大鼠的右侧脑室。在荧光显微镜下观察脑组织切片,以确认Ad组和AdHIF-1α组中重组腺病毒的明确表达。在再灌注后6小时、24小时和72小时,通过免疫组织化学染色分析HIF-1α蛋白的表达。在再灌注后6小时、24小时和72小时评估脑含水量和神经功能缺损评分。在再灌注72小时后,苏木精-伊红染色检查脑病理损伤,末端脱氧核苷酸转移酶介导的dUTP-生物素缺口末端标记(TUNEL)染色测量神经细胞凋亡。不同实验组之间采用单因素方差分析和事后Scheffe检验进行比较。
注射后24小时至21天内,Ad组和AdHIF-1α组的脑组织中成功表达了绿色荧光蛋白。免疫组织化学染色检测显示,与CIR组和Ad组相比,AdHIF-1α组在再灌注后24小时和72小时的HIF-1α蛋白表达明显增强。再灌注后24小时和72小时,AdHIF-1α组的脑含水量(分别为78.83%±0.34% vs. 83.21%±0.50%和83.35%±0.32%;84.13%±0.24% vs. 89.76%±0.34%和89.70%±0.18%;均P<0.05)和神经功能缺损评分(24小时时分别为2.90±0.74 vs. 3.50±0.52和3.60±0.53;72小时时分别为2.40±0.84 vs. 3.60±0.52和3.50±0.53;均P<0.05)与CIR组和Ad组相比均显著降低。再灌注72小时时,AdHIF-1α组的病理变化比CIR组和Ad组轻。再灌注72小时时,与CIR组和Ad组相比,AdHIF-1α组大脑皮层下TUNEL阳性细胞百分比显著降低(P<0.05)。
AdHIF-1α对大鼠脑缺血再灌注具有明显的神经保护作用,可能是通过抑制神经细胞凋亡实现的。